Patents by Inventor Erhard Huesler

Erhard Huesler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130190856
    Abstract: Apparatus and methods for stenting are provided comprising a stent attached to a porous biocompatible material that is permeable to endothelial cell ingrowth, but impermeable to release of emboli of predetermined size. Apparatus and methods are also provided for use at a vessel branching. The present invention further involves porous polymer membranes, suitable for use in medical implants, having controlled pore sizes, pore densities and mechanical properties. Methods of manufacturing such porous membranes are described in which a continuous fiber of polymer is extruded through a reciprocating extrusion head and deposited onto a substrate in a predetermined pattern. When cured, the polymeric material forms a stable, porous membrane suitable for a variety of applications, including reducing emboli release during and after stent delivery, and providing a source for release of bioactive substances to a vessel or organ and surrounding tissue.
    Type: Application
    Filed: March 13, 2013
    Publication date: July 25, 2013
    Applicant: Abbott Laboratories Vascular Enterprises Limited
    Inventors: Randolph von Oepen, Gerd Seibold, Silvio R. Schaffner, Marc G Gianotti, Joost J. Fierens, Erhard Huesler, Arik Zucker, Eric Marcoux, Philippe Nicaise, Sebastien Dubois
  • Publication number: 20110022159
    Abstract: The present invention involves porous polymer membranes, suitable for use in medical implants, having controlled pore sizes, pore densities and mechanical properties. Methods of manufacturing such porous membranes are described in which a continuous fiber of polymer is extruded through a reciprocating extrusion head and deposited onto a substrate in a predetermined pattern. When cured, the polymeric material forms a stable, porous membrane suitable for a variety of applications, including reducing emboli release during and after stent delivery, and providing a source for release of bioactive substances to a vessel or organ and surrounding tissue.
    Type: Application
    Filed: September 30, 2010
    Publication date: January 27, 2011
    Applicant: ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED
    Inventors: Joost J. Fierens, Erhard Huesler, Arik Zucker, Eric Marcoux, Philippe Nicaise, Sebastien Dubois
  • Patent number: 7815763
    Abstract: The present invention involves porous polymer membranes, suitable for use in medical implants, having controlled pore sizes, pore densities and mechanical properties. Methods of manufacturing such porous membranes are described in which a continuous fiber of polymer is extruded through a reciprocating extrusion head and deposited onto a substrate in a predetermined pattern. When cured, the polymeric material forms a stable, porous membrane suitable for a variety of applications, including reducing emboli release during and after stent delivery, and providing a source for release of bioactive substances to a vessel or organ and surrounding tissue.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: October 19, 2010
    Assignee: Abbott Laboratories Vascular Enterprises Limited
    Inventors: Joost J. Fierens, Erhard Huesler, Arik Zucker, Eric Marcoux, Philippe Nicaise, Sebastien Dubois
  • Publication number: 20060175727
    Abstract: The present invention involves porous polymer membranes, suitable for use in medical implants, having controlled pore sizes, pore densities and mechanical properties. Methods of manufacturing such porous membranes are described in which a continuous fiber of polymer is extruded through a reciprocating extrusion head and deposited onto a substrate in a predetermined pattern. When cured, the polymeric material forms a stable, porous membrane suitable for a variety of applications, including reducing emboli release during and after stent delivery, and providing a source for release of bioactive substances to a vessel or organ and surrounding tissue.
    Type: Application
    Filed: December 19, 2005
    Publication date: August 10, 2006
    Applicant: ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED
    Inventors: Joost Fierens, Erhard Huesler, Arik Zucker, Eric Marcoux, Philippe Nicaise